Correlation Between Bionoid Pharma and Avicanna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Avicanna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Avicanna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Avicanna, you can compare the effects of market volatilities on Bionoid Pharma and Avicanna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Avicanna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Avicanna.

Diversification Opportunities for Bionoid Pharma and Avicanna

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bionoid and Avicanna is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Avicanna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avicanna and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Avicanna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avicanna has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Avicanna go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Avicanna

Given the investment horizon of 90 days Bionoid Pharma is expected to generate 3.7 times more return on investment than Avicanna. However, Bionoid Pharma is 3.7 times more volatile than Avicanna. It trades about 0.08 of its potential returns per unit of risk. Avicanna is currently generating about -0.14 per unit of risk. If you would invest  25.00  in Bionoid Pharma on August 25, 2024 and sell it today you would lose (5.00) from holding Bionoid Pharma or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bionoid Pharma  vs.  Avicanna

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
Avicanna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avicanna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Bionoid Pharma and Avicanna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Avicanna

The main advantage of trading using opposite Bionoid Pharma and Avicanna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Avicanna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avicanna will offset losses from the drop in Avicanna's long position.
The idea behind Bionoid Pharma and Avicanna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments